To Reduce Chronic Pain: Small Amount of Cannabis can Be Used Without Getting 'high'

Low Dose of cannabidiol containing Cannabis can effectively treat Chronic pain without increasing the risk of addiction, finds a new study.

The exact dosage of plant extract cannabidiol (CBD) displaying analgesic and anti-anxiety properties can be used for chronic pain treatment without the addiction risk has been found in this study. The findings of this study are published in the PAIN Journal.

In the wake of cannabis legalization, a team of scientists at the Research Institute of the McGill University Health Centre (MUHC) and McGill University have delivered encouraging news for chronic pain sufferers by pinpointing the effective dose of marijuana plant extract cannabidiol (CBD) for safe pain relief without the typical "high" or euphoria produced by the THC. The findings of their study have been published in the journal PAIN (The Journal of the International Association for the Study of Pain).

Meditation, Mindful Breathing Can Help Patients Manage Chronic Pain
Complementary practices like meditation and mindful breathing can help patients manage chronic pain and also reduced the need for medication such as opioids in some cases.

‘In the study, it was found that low doses of CBD administered for seven days alleviate both pain and anxiety in chronic pain patients.’

Cannabis indica and sativa are the two main cannabis strains that produce the pharmacological principles known as tetrahydrocannabinol (THC) and cannabidiol (CBD).

Dr. Gabriella Gobbi’s team demonstrated that CBD does not act on the CB1 cannabinoid receptors like THC but through the mechanism that binds specific receptors involved in anxiety (serotonin 5-HT1A) and pain (vanilloid TRPV1).

Researchers were able to extrapolate the exact dosage of CBD displaying analgesic and antianxiety properties without the risk of addiction and euphoria classically produced by the THC.

Novel Pain-Sensing Brain Network Linked to Chronic Pain in Parkinson's Disease: Study
Subthalamic nucleus is a likely target for pain relief in Parkinson's disease (PD), finds a new study

"We found in animal models of chronic pain that low doses of CBD administered for seven days alleviate both pain and anxiety, two symptoms often associated in neuropathic or chronic pain," says first author of the study Danilo De Gregorio, a post-doctoral fellow at McGill University in Dr. Gobbi’s laboratory.

Lead author Dr. Gobbi, a researcher in the Brain Repair and Integrative Neuroscience (BRaIN) Program of the RI-MUHC, sees this as advancement for the evidence-based application of cannabis in medicine with CBD offering a safe alternative to THC and opioids for chronic pain, such as back pain, sciatica, diabetic, cancer and post-trauma pain.

Common Painkiller Ineffective for Chronic Pain After Traumatic Nerve Injury: Study
Pregabalin, common painkiller is ineffective in managing the long-term pain for traumatic injury but it may provide relief for patients who experience pain after surgery.

"Our findings elucidate the mechanism of action of CBD and show that it can be used as medicine without the dangerous side effects of the THC," says Dr. Gobbi, who is also Professor of Psychiatry at the Faculty of Medicine at McGill University and staff psychiatrist at the MUHC. "This research is a new advancement for an evidence-based application of cannabis in medicine."

Despite widespread public usage, little clinical studies exist on CBD, which became legal in Canada on October 17, 2018, following the passage of Canada’s Cannabis Act.

Women Veterans More Likely to Use Yoga and Acupuncture to Manage Chronic Pain
Women more likely than men to use alternative pain therapies to treat chronic pain finds a new study.

"There is some data showing that CBD provides pain relief for humans, but more robust clinical trials are needed," says Dr. Gobbi, a recent grant recipient for her study of the pharmacological effects of CBD.

Source-Eurekalert